Evofem Biosciences Reported Earnings

Evofem Biosciences (EVFM) reported a loss of $0.06 per share on revenue of $2.63 million for the . . Revenue fell 45.43% compared to the same quarter a year ago.

Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.